Trade Summary

6 days ago, Mayes Patrick A, serving as EVP & Chief Scientific Officer at INCYTE CORP (INCY), sold 2,207 shares at $123.99 per share, for a total transaction value of $273,645.93. Following this transaction, Mayes Patrick A now holds 61,441 shares of INCY.

This sale represents a 3.47% decrease in Mayes Patrick A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 4:01 PM ET, 2 days after the trade was made.

INCYTE CORP operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.